Objective: We analyzed the long-term morbidity and mortality of our ex
perience,vith combined mitral-aortic surgery, as well as their determi
nants. Methods: Among 2109 consecutive patients undergoing valve opera
tions, 200 had mitral-aortic valve procedures with at least implantati
on of a mechanical prosthesis: 163 of 200 (81.5%) patients had double
valve replacement and 37 of 200 (18.5%) had mitral valve repair and ao
rtic valve replacement. All mechanical valves,were bileaflet prosthese
s. Preoperatively, 171 of 200 (85.5%) patients were in New York Heart
Association class III-IV. Event-free survivals were determined by mean
s of the Kaplan-Meier method and determinants of survivals with the Co
x proportional hazards model (p < 0.05) entering 39 preoperative and p
erioperative factors. Follow-up was complete for 96% of the patients (
192/200), Results: Overall survivals at 5, 10, and 15 gears were 88.5%
+/- 0.55%, 73.5% +/- 4%, and 53.3% +/- 8.9%, and rates of freedom fro
m valve-related mortality were 92.9% +/- 1.5%, 85.8% +/- 3.5%, and 85.
8% +/- 3.5%, The rates of freedom from permanent valve-related impairm
ent were 91.5% +/- 1.7%, 85.4% +/- 3.5%, and 79.3% +/- 6.7%, and those
from all valve-related mortality and morbidity were 74.1% +/- 2.3%, 5
3.8% +/- 5%, and 49% +/- 5.6%, At last follow-up, 90% (139/154) of the
survivors were in New York Heart Association class I-II. Left ventric
ular ejection fraction less than 50%, age older than 70 years, and pre
operative ventricular arrhythmias were independent risk factors for va
lve-related late deaths, Diabetes, ejection fraction less than 50%, an
d coronary artery disease were independent determinants of all valve-r
elated events. Conclusions: Functional results of survivors of combine
d mitral-aortic surgery are excellent. However long-term valve-related
morbidity and mortality are substantial. In the patient population st
udied, the predictors are determined by patient-related factors, mainl
y myocardial factors, but not by valve-related factors.